Cargando…
How to Effectively Support Patients with Rheumatic Conditions Now and Beyond COVID‐19
Autores principales: | Décary, Simon, Barton, Jennifer L., Proulx, Laurie, Richards, Dawn P., Paterson, Gail, de Wit, Maarten, Toupin‐April, Karine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272921/ https://www.ncbi.nlm.nih.gov/pubmed/32403182 http://dx.doi.org/10.1002/acr2.11152 |
Ejemplares similares
-
Identifying potential barriers and solutions to patient partner compensation (payment) in research
por: Richards, Dawn P., et al.
Publicado: (2022) -
Incidence of blindness in a population of rheumatic patients treated with hydroxychloroquine
por: Singh, Dilpreet K, et al.
Publicado: (2019) -
Dual biologic therapy for the treatment of rheumatic diseases and asthma: a case series
por: Malik, Mariam, et al.
Publicado: (2023) -
Failure of chronic hydroxychloroquine in preventing severe complications of COVID-19 in patients with rheumatic diseases
por: Pham, Khanh, et al.
Publicado: (2021) -
COVID-19-related anxiety trajectories in children, young people and adults with rheumatic diseases
por: Shoop-Worrall, Stephanie J W, et al.
Publicado: (2023)